Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1653.6059.75 (+3.75 %)

PREV CLOSE ( ) 1593.85

OPEN PRICE ( ) 1585.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 69170

TODAY'S LOW / HIGH ( )1574.70 1672.65

52 WK LOW / HIGH ( )890 1672.65

NSE1652.7059.3 (+3.72 %)

PREV CLOSE( ) 1593.40

OPEN PRICE ( ) 1593.40

BID PRICE (QTY) 1652.70 (39)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 946487

TODAY'S LOW / HIGH( ) 1576.30 1671.80

52 WK LOW / HIGH ( )889 1671.8

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

9713.49

7272.28

7472.15

9725.48

6573.27

Adjustment

5515.12

5431.47

4923.49

3987.42

5820.95

Changes In working Capital

-4242.98

505.17

-2922.35

-2919.06

-3345.54

Cash Flow after changes in Working Capital

10985.63

13208.92

9473.29

10793.84

9048.68

Cash Flow from Operating Activities

8517.05

10972.40

7468.53

7682.07

7044.35

Cash Flow from Investing Activities

-940.01

-7125.12

-4676.85

-7887.91

-2518.48

Cash Flow from Financing Activities

-8139.57

-1642.06

-1453.97

-1518.51

-1889.04

Net Cash Inflow / Outflow

-562.53

2205.22

1337.71

-1724.35

2636.83

Opening Cash & Cash Equivalents

439.91

-1745.29

-3081.72

-3500.42

-6091.08

Cash & Cash Equivalent on Amalgamation / Take over / Merger

2141.19

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

-20.49

-20.02

-1.28

1.86

-46.17

Closing Cash & Cash Equivalent

-143.11

439.91

-1745.29

-3081.72

-3500.42